Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseGraves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hyperthyroidism, immune system disorder, thyroid gland disorderRecruitingPhase 22026-08-25NCT06727604

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunovant Sciences GmbH8

134 results · Page 1 of 6

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site Number - 1001Los AngelesUnited States1
Site Number - 1002AustinUnited States1
Site Number - 1003PortlandUnited States1
Site Number - 1004MesquiteUnited States1
Site Number - 1005TorranceUnited States1
Site Number - 1006Walnut CreekUnited States1
Site Number - 1007Las VegasUnited States1
Site Number - 1008RochesterUnited States1
Site Number - 1009Round RockUnited States1
Site Number - 1010NewarkUnited States1
Site Number - 1011OrlandoUnited States1
Site Number - 1012West Palm BeachUnited States1
Site Number - 1013EnglewoodUnited States1
Site Number - 1014San AntonioUnited States1
Site Number - 1015SummervilleUnited States1
Site Number - 1016Port CharlotteUnited States1
Site Number - 1017OmahaUnited States1
Site Number - 1018Farmington HillsUnited States1
Site Number - 1019DallasUnited States1
Site Number - 1020StockbridgeUnited States1
Site Number - 1022New OrleansUnited States1
Site Number - 1023BaltimoreUnited States1
Site Number - 1025HoustonUnited States1
Site Number - 1026BostonUnited States1
Site Number - 1027IndianapolisUnited States1